Search

Your search keyword '"Schuster, Jennifer E."' showing total 442 results

Search Constraints

Start Over You searched for: Author "Schuster, Jennifer E." Remove constraint Author: "Schuster, Jennifer E."
442 results on '"Schuster, Jennifer E."'

Search Results

1. NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

2. On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network

3. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications--United States, 2023-2024

4. Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

5. Humoral and cellular response to the COVID-19 vaccine in immunocompromised children

6. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients

7. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

8. Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network

9. NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

11. Contributors

12. The Modified Clinical Progression Scale for Pediatric Patients: Evaluation as a Severity Metric and Outcome Measure in Severe Acute Viral Respiratory Illness

13. Association of Asthma With Treatments and Outcomes in Children With Critical Influenza

14. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season--New Vaccine Surveillance Network, October 2023-February 2024

16. Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control Investigation

17. Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016–2022

18. Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children

19. Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies

20. Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents

21. Maternal Vaccination and Risk of Hospitalization for Covid-19 Among Infants

22. SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years--New Vaccine Surveillance Network, United States, July 2022-September 2023

24. Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.

26. Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022.

27. Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024

28. Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification

29. Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018–2024

30. School-Based Surveillance of Mycoplasma pneumoniae Trends and Impact on School Attendance by Students and Staff Members -- Missouri, Fall 2024.

31. Influenza C virus in U.S. children with acute respiratory infection 2016–2019

33. Contributors

35. Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023.

36. 2644. Presence of Respiratory Viruses in the Upper Respiratory Tract of Febrile Infants ≤90 Days Old is Associated with Lower Prevalence of Invasive Bacterial Infection

37. 1755. Hospitalizations for Respiratory Viruses among Children 5–17 Years of Age in the Pre-COVID-19 Pandemic Era, the New Vaccine Surveillance Network, 2016–2020

39. 1733. Effectiveness of Influenza Vaccination Against Influenza-Associated Emergency Department (ED) Visits and Hospitalizations Among Children With and Without Underlying Medical Conditions, New Vaccine Surveillance Network (NVSN), 2015-2016 through 2019-2020 Influenza Seasons

40. 1752. Seasonal Human Coronavirus in Pediatric Patients enrolled by the New Vaccine Surveillance Network, 2016-2020

42. 1104. Characteristics and Seasonality of Children Hospitalized with Parainfluenza Virus Infections (PIV), including PIV-4, New Vaccine Surveillance Network, 2016–2020

43. 1101. Antiviral Prescription in Children with Influenza in Emergency Departments (ED): New Vaccine Surveillance Network (NVSN), 2016–2020

45. 905. Epidemiology of Enterovirus D68 in the US: New Vaccine Surveillance Network, 2017–2022

47. 2652. Detection of respiratory viruses by air sampling and student and staff surveillance testing in two elementary schools

48. 1742. Predictors of Antiviral Receipt for Influenza in Hospitalized U.S. Children, New Vaccine Surveillance Network (NVSN), 2016–2020

49. 1754. Parainfluenza Virus Co-detection With Respiratory Syncytial Virus or Influenza is Associated with Higher Odds of Hospitalization in Children &lt; 2 Years Old, New Vaccine Surveillance Network (NVSN), 2016–2020

Catalog

Books, media, physical & digital resources